Chiesi Group

Casa
Italia
Parma
Chiesi Group

International pharmaceutical Group certified B Corp.

23/04/2026

2025 was a year of strong performance for Chiesi. Revenues reached €3.6bn, with a record €885m invested in R&D, driven by innovation, resilience and sustainability.
Thank you to our 7,900+ colleagues worldwide as we move into 2026 with confidence and continue to deliver for patients acting as a force for good.
We also thank Giuseppe Accogli for his contributions to Chiesi’s growth and Jean‑Marc Bellemin for stepping in as Interim CEO to ensure continuity and momentum as we enter the next phase of our journey.

🔗 More on our FY2025 results: https://www.chiesi.com/en/media-hub/press-releases/chiesi-reports-strong-fy2025-financial-sustainability-results

22/04/2026

What does a net zero future look like? 🌍

Earth Day is a moment to reflect on the role we all play in shaping a more sustainable future. At Chiesi, we see this as a long-term commitment and we are working to reduce our environmental impact over time, guided by the ambition to reach net zero greenhouse gas emissions by 2035.

17/04/2026

How do different generations picture the future of Chiesi?

Andrea and Elba share their views on what’s ahead and what should always stay the same: people, collaboration, and supporting one another.

By bringing together different experiences and career stages, their conversation captures the essence of Gen2Gen, a series created to spark meaningful dialogue across generations.

15/04/2026

Some challenges are visible, others quietly shape everyday life. For people living with , symptoms often influence the rhythm of each day.

During Fabry Disease Month, we’re reminded how meaningful small moments can be. Whether it’s spending time with family, enjoying a hobby, or simply finding a few minutes of stillness, these moments can offer a sense of grounding — the strength needed to face what the disease brings.

Chiesi Global Rare Diseases

27/03/2026

Behind the data, there are people who listen, connect, and build trust.

On International Medical Science Laison Day, we celebrate the MSLs who turn science into meaningful conversations, bringing insights from the field, supporting clinicians, and helping keep patients at the heart of every decision.
Discover the voices of our MSL colleagues and how their work contributes to the shared purpose of improving the patient journey.

18/03/2026

Every patient's story is unique. Each one offers a perspective that helps us look beyond clinical needs and better understand the human experience of care.
Listening to patients allows us to notice what might otherwise be missed - where things feel unclear, where support falls short, and what truly makes a difference along the way. These insights guide how we improve, step by step.

Take a moment to listen to the community's voices as they share their experiences throughout their journeys - because understanding begins with listening.

08/03/2026

Equity means more than metrics: it’s a journey to foster access, visibility, and meaningful support for every talent.
At Chiesi, we keep empowering women at every stage of their career by providing equal opportunities and fair pay, ensuring balanced gender representation in leadership roles, and supporting their growth through dedicated mentoring, coaching, and networking programs.

This , we celebrate progress and reaffirm our commitment to creating an environment where women can thrive.

28/02/2026

Listening connects us, to each other, to our communities, and to people living with rare diseases around the world.

This , through our immersive “Sound of Rare” experience, colleagues across the globe took a moment to truly listen to the voices and stories of the rare disease community.

Afterward, each person wrote down one key learning. Every note was then linked together to form a paper chain, a visual reminder of how listening brings us closer and strengthens our connection as a global community.
Learn more at: https://www.rarediseaseday.org/

Chiesi Global Rare Diseases

12/02/2026

Tackling climate-related respiratory disease means tackling inequality.

The most vulnerable communities breathe dirtier air, face longer allergy seasons, and often miss early diagnosis. Non-physiological factors—income, housing, occupation, education, access to care and local air quality—have the greatest influence on lung health.

While pollution remains Europe’s biggest environmental health challenge, we have the power to change that.
By acting now, Europe can lead the way with cleaner cities, stronger health systems, and safer workplaces—helping to prevent asthma and COPD (Chronic Obstructive Pulmonary Disease) and protect those most at risk. Together, we can turn this challenge into progress.

Learn more at: https://ow.ly/OBYf50Yebt7

11/02/2026

From discovery to regulatory affairs, our colleagues advance science every day to improve people’s lives.

On the International Day of Women and Girls in Science, we celebrate the passion, ideas and vision of the women in our R&D community and share what inspires them to keep moving science forward.

Meet the people behind the progress!👩‍🔬

22/01/2026

È stata rinnovata la certificazione UNI/PdR 125 sulla parità di genere per Chiesi Farmaceutici S.p.A. e Chiesi Italia, un riconoscimento che premia il nostro impegno costante nel garantire equità e inclusione in ogni ambito della vita aziendale.

La parità di genere è parte integrante della nostra cultura: garantiamo equità retributiva, trasparenza e politiche di welfare che supportano ogni fase della vita, inclusi i congedi di genitorialità retribuiti al 100% per tutti i genitori.

Questo risultato rappresenta un ulteriore passo avanti verso un ambiente di lavoro in cui ciascuno può esprimere pienamente il proprio potenziale.

20/01/2026

Understanding patients' needs is the starting point for real innovation in healthcare.

At Chiesi, the Patient Journey framework is central to our patient-driven approach. It helps us map every step, from the awareness of health conditions and risk factors to diagnosis, treatment, and follow-up care.

By capturing not only the patient’s experience but also the perspectives of all stakeholders involved, it enables us to co-create integrated, sustainable solutions that go beyond the product.

🎥 Watch Noemi's video to learn how we turn insights into impact.

Indirizzo

Via Palermo 26A
Parma
43122

Sito Web

http://www.chiesi.com/

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Chiesi Group pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Contatta Lo Studio

Invia un messaggio a Chiesi Group:

Vuoi che la tua studio sia il Clinica più quotato a Parma?

Digitare

Azienda farmaceutica

Who we are

Chiesi is an international company originated in Parma, with 85 years of experience and a strong focus on research, development, production and commercialization of innovative therapeutic solutions in the Respiratory, Neonatology, Rare Diseases and Special Care Therapeutic Areas. We are value-oriented, passionate, supportive and a global family with nearly 6.000 employees and 29 affiliates who have a real impact on people's lives in 90 countries around the world. With a turnover of nearly €2 billion sales, we are among the top 50 pharmaceutical companies in the world. Chiesi is the largest global pharmaceutical Group to be awarded B Corp Certification, a recognition of high social and environmental standards. We want to use business as a force for good and create a positive impact on people, environment and community.